Controlled Cell Death

October 05, 1998

Life without death is inconceivable. Cell death, also known as apoptosis, is vital for an organism. During the development of adult organisms, structures are properly formed which requires that cells are removed in a controlled manner. If apoptosis does not take place, the effects can be serious.

Certain forms of cancer and autoimmune diseases can be traced back to a lack of apoptosis; the death of nerve cells in certain forms of Alzheimer's disease and also possibly the damage done to the brain after a stroke are the result of too much apoptosis. This basic meaning of cell death for the survival of an organism explains why a large number of scientists are working to gain more insight into the molecular mechanism which underlie this phenomenon.

Scientists at the Max Planck Institute of Biophysical Chemistry in Göttingen have shed light upon the function of the gene which acts as a switch in the chain of the molecular process and which leads to the death of a cell (Cell, Vol 94, September 18, 1998). This gene, Apaf1 (Apoptotic protease activating factor 1) plays a central role in programmed cell death in mammals. The scientists used mice in their studies to decipher the role of this gene. They could show that this gene is important for the embryonal development of the mouse. They were also able to better define the position of the corresponding gene products in the hierarchy of events which lead to cell death.

Apaf1, as a key component of apoptosis, could become a very attractive object for many areas of medical research, for the development of new anti-cancer strategies, the treatment of neurodegenerative diseases (Alzheimer's) and other genetic diseases, which involve a malfunction of the apoptosis pathway.
-end-
Original publication Cecconi, F., G. Alvarez-Bolado, B. Meyer, K. Roth and P. Gruss: Apaf1 (CED-4 Homolog) regulates programmed cell death in mammalian development.
Cell, Vol. 94: 727-737, September 18, 1998
Published: 5-10-98
Contact: Prof. Peter Gruss
Dr. Francesco Cecconi
Max Planck Institute for Biophysical Chemistry,
Göttingen, Germany
Phone: 49-551-201-1361
Fax: 49-551-201-1504

Max-Planck-Gesellschaft

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.